Delivery Order SPE2DB20D1109-SPE2DB21FP66J
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $2,099.76 Firm Fixed Price delivery order is for a Prime Vendor Pharmaceutical Branch-Philadelphia, with an ultimate completion date of December 1, 2020. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,231.45 firm fixed-price delivery order is for the Prime Vendor Pharmaceutical Branch-Philadelphia program, with a completion date of December 23, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,889.92 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of May 25, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract is not designated with any...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,193.82 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a period of performance through June 2021. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,317.10 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of September 10, 2020. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,914.32 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical contract, with an ultimate completion date of March 3, 2021. Amerisourcebergen, a subsidiary of Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order worth $1,311.38 for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" from the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,097.49 firm fixed-price delivery order is for the Prime Vendor Pharmaceutical Branch-Philadelphia, with an ultimate completion date of August 20, 2020. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,898.00 Firm Fixed Price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with an ultimate completion date of October 27, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award from the Defense Logistics Agency (DLA) is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,401.60 fixed-price contract provides a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities and veteran healthcare programs....
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB21FP66JDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,143.55 firm fixed-price delivery order is for a Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of July 28, 2021. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC, which runs through November 2026, serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, Amerisourcebergen holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024 for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 7/27/21 |